AJU IB Investment Co., Ltd.

CIK: 0001710065Latest portfolio: $22.8M · Q4 2025

Holdings

Total Value

$22.8M

New Positions

Closed Positions

Top Holdings

#	Stock	Shares	Value	% Portfolio	Change
1	ACLXARCELLX INC	223,486	$14.6M	63.94%	NEW
2	RLYBRALLYBIO CORP	754,678	$4.1M	18.18%	NEW
3	KYMRKYMERA THERAPEUTICS INC	19,648	$1.5M	6.71%	NEW
4	SEERSEER INC	816,375	$1.5M	6.55%	NEW
5	XLOXILIO THERAPEUTICS INC	667,742	$427K	1.87%	NEW
6	RAPTEURRAPT THERAPEUTICS INC	12,437	$421K	1.85%	NEW
7	STROSUTRO BIOPHARMA INC	17,500	$202K	0.89%	NEW

Quarterly Changes

New Positions

ACLXNEW
$14.6M
RLYBNEW
$4.1M
KYMRNEW
$1.5M
SEERNEW
$1.5M
XLONEW
$427K
RAPTEURNEW
$421K
STRONEW
$202K

Closed Positions

No closed positions this quarter

Sector Breakdown

Healthcare0.0% ($14571414215281.5T)

Unknown0.0% ($421K)

Filing History

Quarter	Filing Date	Portfolio Value	Holdings
Q4 2025	Feb 10, 2026	$22.8M	7
Q3 2025	Nov 6, 2025	$115.1B	0
Q2 2025	Jul 10, 2025	$91.9B	8
Q1 2025	Apr 8, 2025	$102.8B	8
Q1 2025	Apr 8, 2025	$84.0B	8

Fund Information

CIK0001710065

Most Recent FilingFeb 10, 2026

Number of Filings5

View on SEC EDGAR →

AJU IB Investment Co., Ltd. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $22.8M across 7 holdings. The largest position is ARCELLX INC (ACLX), representing 63.9% of the portfolio. Compared to the previous quarter, the fund opened 7 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.